home / stock / antx / antx quote
Last: | $ |
---|---|
Change Percent: | -1.27% |
Open: | $57.76 |
Close: | $56.86 |
High: | $58.14 |
Low: | $56.86 |
Volume: | 315,708 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $57.76 | $56.86 | $58.14 | $56.86 | 315,708 | 04-30-2018 |
$ | $56.92 | $57.59 | $57.86 | $56.92 | 4,322,357 | 04-27-2018 |
$ | $58.27 | $57.22 | $59.10 | $57.00 | 4,430,352 | 04-26-2018 |
$ | $55.00 | $57.61 | $57.71 | $53.8601 | 1,725,049 | 04-25-2018 |
$ | $54.85 | $54.31 | $54.99 | $53.95 | 3,790,173 | 04-24-2018 |
$ | $54.50 | $54.5654 | $55.069 | $54.43 | 303,300 | 04-23-2018 |
$ | $55.00 | $54.51 | $55.31 | $54.33 | 18,693 | 04-20-2018 |
$ | $55.54 | $54.9354 | $55.67 | $54.7454 | 10,772 | 04-19-2018 |
$ | $55.40 | $55.65 | $55.77 | $55.3298 | 554,234 | 04-18-2018 |
$ | $54.64 | $55.36 | $55.8199 | $54.64 | 3,705,905 | 04-17-2018 |
$ | $53.78 | $54.34 | $54.58 | $53.77 | 496,156 | 04-16-2018 |
$ | $53.61 | $53.50 | $53.86 | $53.46 | 370,962 | 04-13-2018 |
$ | $53.60 | $53.19 | $53.78 | $53.12 | 2,404,746 | 04-12-2018 |
$ | $54.10 | $53.75 | $54.10 | $53.74 | 4,488 | 04-11-2018 |
$ | $54.83 | $54.82 | $54.91 | $54.70 | 17,504 | 04-10-2018 |
$ | $55.37 | $54.37 | $55.37 | $54.31 | 121,751 | 04-09-2018 |
$ | $55.81 | $54.92 | $56.09 | $54.41 | 64,619 | 04-06-2018 |
$ | $55.96 | $56.36 | $56.44 | $55.6795 | 127,237 | 04-05-2018 |
$ | $55.30 | $55.85 | $55.85 | $54.85 | 22,219 | 04-04-2018 |
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 4.6% to $128.28 on volume of 215,349,874 shares Zoomcar Holdings Inc. (ZCAR) rose 34.0% to $0.183 on volume of 204,010,215 shares Maxeon Solar Technologies Ltd. (MAXN) fell 3.5% to $0.1736 on volume of 2...
Plan to report Phase 2 topline results in August 2024 from ongoing Phase 2/3 trial (EBO-301) in treatment-refractory Mycobacterium avium Complex (TR-MAC) Phase 3 continues for 97 patients enrolled before the voluntary enrollment pause; lifting of the Phase 3 enrollment pause to be determi...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...